A Day Up For Genprex, Inc.
Wed, Jan 29, 2020 at 05:30 PM
Genprex, Inc. (GNPX:NASDAQ) jumped higher at $1.58, a gain of 23.4%. The stock got featured on our News Catalysts scanner on Wed 29 Jan 20 at 09:00 AM in the 'BIOTECH' category. From Tue 07 Jan 20, the stock recorded 35.71% Up Days and 33.33% Green Days
The stock spiked on Wed 22 Jan 20 at $2 with a volume of 42M+.
About Genprex, Inc. (GNPX:NASDAQ)
Genprex Inc is a clinical stage gene therapy company. It develops therapies that carry cancer-fighting genes. Its initial product candidate is Oncoprex.
Top 10 Gainers:
- Lee Enterprises, Incorporated (LEE:NYSE), 66.67%
- Vivint Smart Home, Inc. (VVNT:NYSE), 46.61%
- Roadrunner Transportation Systems, Inc. (RRTS:NYSE), 41.34%
- ReTo Eco-Solutions, Inc. (RETO:NASDAQ), 33.72%
- Clearwater Paper Corporation (CLW:NYSE), 27.05%
- Mediaco Holding Inc. (MDIA:NASDAQ), 24.68%
- BIO-key International, Inc. (BKYI:NASDAQ), 24.37%
- Genprex, Inc. (GNPX:NASDAQ), 23.44%
- 89bio, Inc. (ETNB:NASDAQ), 23.12%
- ATIF Holdings Limited (ATIF:NASDAQ), 22.22%